SkinHealth Systems (SKIN) Common Equity (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Common Equity data on file, last reported at $55.2 million in Q1 2026.

• On a quarterly basis, Common Equity rose 19.93% year-over-year to $55.2 million in Q1 2026; TTM through Mar 2026 was $55.2 million, a 19.93% increase from a year earlier, with the FY2025 full-year figure at $61.1 million, up 17.86% from the prior year.
• Common Equity for Q1 2026 stood at $55.2 million, down from $61.1 million in the prior quarter.
• Over the last five years, Common Equity for SKIN reached as high as $345.4 million in Q2 2022 and fell as low as $46.1 million in Q1 2025.
• Historically, Common Equity has averaged $124.1 million across 5 years, with a median of $69.2 million in 2024.
• Across the five-year window, Common Equity jumped 2049.38% in 2022 and sank 64.45% in 2023, its largest moves.
• Year by year, Common Equity stood at $167.1 million in 2022, then sank by 64.45% to $59.4 million in 2023, then decreased by 12.77% to $51.8 million in 2024, then rose by 17.86% to $61.1 million in 2025, then fell by 9.53% to $55.2 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $55.2 million in Q1 2026, $61.1 million in Q4 2025, and $65.7 million in Q3 2025.